Beijing Wantai Biological Pharmacy Enterprise Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Zhiming Jiang
Chief executive officer
CN¥2.3m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.5yrs |
| CEO ownership | n/a |
| Management average tenure | 1.5yrs |
| Board average tenure | 3.7yrs |
Recent management updates
Recent updates
Does Beijing Wantai Biological Pharmacy Enterprise (SHSE:603392) Have A Healthy Balance Sheet?
Jan 24
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) Analysts Are Reducing Their Forecasts For This Year
Jul 26These 4 Measures Indicate That Beijing Wantai Biological Pharmacy Enterprise (SHSE:603392) Is Using Debt Reasonably Well
Jul 22CEO
Zhiming Jiang (52 yo)
Ms. Zhiming Jiang is General Manager and Director of Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. since January 15, 2024 and April 19, 2024 respectively.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 1.5yrs | CN¥2.28m | no data | |
| Chief Financial Officer | 1.3yrs | CN¥899.50k | no data | |
| Board Secretary | 1.9yrs | CN¥1.49m | 0.029% CN¥ 21.7m | |
| Accounting Supervisor | no data | no data | no data |
Experienced Management: 603392's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 1.3yrs | CN¥2.28m | no data | |
| Chairman | 4.3yrs | CN¥1.80m | 3.54% CN¥ 2.6b | |
| Independent Director | 4.3yrs | CN¥193.90k | no data | |
| Independent Director | 3.2yrs | CN¥193.90k | no data | |
| Chairman of Supervisory Board | 7.3yrs | no data | no data | |
| Supervisor | 4.3yrs | no data | no data | |
| Employee Supervisor | 4.3yrs | no data | no data | |
| Director | 1.3yrs | no data | no data | |
| Director | 1.3yrs | no data | no data | |
| Independent Director | 1.3yrs | CN¥147.80k | no data |
Experienced Board: 603392's board of directors are considered experienced (3.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/15 08:47 |
| End of Day Share Price | 2025/07/15 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Yizhang Zhu | Citic Securities Co., Ltd. |
| Yinglan Shu | Haitong International Research Limited |